Page 287 - Radiochemistry and nuclear chemistry
P. 287

Uses of Radioactive  Tracers                 271



              9.5.3.  Emission  computer tomography (ECT) and diagnosis

                The  rate  of incorporation  and  discharge of radioactively  labeled  substances  in the  body
              provides  a  measure of the  metabolism of healthy and  of sick tissues.  On  medical  patients
              this information is obtaineA by external  measurements referred to as radioisotope scanning
              (RIS).  Such  scanning  can  yield  information  about  a  medical  disorder  much  before  it  is
              observed  by  other  means.  Since  the  amount  of  radioactive  tracer  is  very  small,  this
              technique  is referred to as non-invasive.  In hospitals the department of nuclear medicine is
              normally  responsible  for these  investigations.
                (a)  Simple scanners
                Simple  scanners  are  designed  either  with  one  or  several  direction  sensitive  (focusing)
              detectors,  which are moved around or above the patient in a pattern;  Figure 9.13.B  and C.
              Figure  9.14  shows  the result of a kidney  scan,  renography,  of a  38  year old woman who
              has been administered  197HGC12 (EC'), tt/~ 2.672 d);  in this case a single NaI(TI)-PMT with
              collimator  was  moved  in  a  recti-linear  pattern  over  the  kidneys  (Fig.  9.13.B).  The  left
              picture shows that 38.9 % of the compound has been fixed to the left kidney, and very little
              to the fight kidney. This was caused by a vaginal fibrous sarcoma blocking the urethra from
              the  fight  kidney.  After  radiation  therapy  some  improvement  is  seen  (fight  Figure).
              Renography  is now done with  131I labeled  hippuric  acid,  or a 99mTc complex.
                (b)  Gamma  Camera and Single Photon Emission Computer Tomography (SPECT)
                Recent advances in nuclear medical imaging are the gamma camera,  SPECT and positron
              emission  tomography  (PET,  described  under  (c)).
                Figure  9.13.C  shows  the  gamma  scintillation  camera,  gamma  camera,  originally
              developed  by  Anger.  It  consists  of  a  two-dimensional  array  of  40  -  100  PMTs  (often
              hexagonally  formed  for  tight  stacking) viewing a  large  flat  NaI(T1) crystal  of  --  400 mm
              diameter  and  5  -  10  mm  thick,  which  is  located  behind  a  lead  collimator  containing
              numerous  holes.  Typical  hole  size  is  2  -  3  mm  diameter  and  40  mm  length.  Collimator
              dimensions  (Fig.  9.13.D)  depend  on the E.~; for 99mTc (E.y 0.14  MeV)  the wall  thickness
              is 0.2  - 0.3  mm.




                         .   .  .  "...."  .t'
                         9  9 ..  ;  ..:  ,:  ~,   .',  ,   .',"   .'..:.,;,.  ,.:.,~,,.~  I.;I  ;','~':'  I   ,"  ,..  :  .  ..,  !!;  ":,.'.:.,'................  ......  .  ."   .:  .,
                                                                       :',.
                                               *.
                                                     t  ,  "'l;).',
                                                                    .....
                                                 I
                                                           |t~t~,,'
                                                                  .'.
                                                                         :~
                                                                0:'
                                                                       .....
                                                           ~
                        9  '~,:; ~I~,~   I.  ,.:.'  ';  '.:  '.', (/i   '~ ~ '. :: ~.~". ~'  . ','. '..  .  '. '..'..,, ....; t  :,.,,..' ," .... .:,',,,'.'  .'.-., ,: ", ..' .. ": ..........  9 .  '  .
                                 i~   a#.  ~   ,  ~',  (  ,"  ,',,:,',l  '~',~  I,~,1  ~,....  ......  .':.,  ....   .$.11:,   ..,  '..  v  ,.:..,..  ;  .....   ".
                                                      !  ,...,  =.'-,ri~';,-~.,'~k:':,  ....
                                                                    -'  "" ....
                                                 !  I
                                               !'
                                                        .r;:
                                           ,',  ..,"
                                                               ,'1  .;  .................
                                                    1:
                                                                         I  '  "  .,.....
                                      ,  '....,,
                                   /'
                                                       .  .s
                                                                    .'  ,1'  "  ~Jl.,;"i.'.  ......
                                                ,,.  ,.'  .....
                                     ;,,  ,.:;~',:.~:,  I.,,:.  ,....  .... .~~,.,  .,I| ......  ....::,,,i~,~.,.,,...:....  ,
                                 ~l~,:  ,',  '.   9 '."  :  'o  I,  ':':,~.  ,,,  I  ~  '  .':  '...';.',:,   r'.'."   .....   ~.': ........   .:
                                                       ;
                                                     ~ ....  ; ~ ~ ~
                                                                        ~'";;"
                                                                           ....
                                                 ....
                       .  ~/~tr      $   .*  .  ..........   I  !,....   ::.,::,.,.,.~__.,,,..,   ......   ..'~}~,r.r,~','.".'".',"" '  "  ..  i
                                  '":':                              " ' '  .....
                                                                '.'  .'...'.',".'".~'~l;~,'.~
                                                               ~"
                                                                 ...
                                                                            ...:.:.
                                                                     .,..  ....
                                                                        ~,:.~.~..
                                          9  .
                                                    '.'.'.",
                                  i I   .  '  "  ..   '  "","'"  ..~,..'.'   "  '  ,   ....,:,~.   :1".'.'..'"  ";~:,,,,:'t~:'~  r!,~:~:::.:.,
                                  :"  '   '  ."  ;  ':  I  ':  '."  :  '.'..;.:
                                  ,      "  ",  '"  '.  ;  '   .  :.  :'..:~~:',.7,"   ..  ..,  ::,,.;..~r~,..,.~',...';~::--.
                                 y,  ,..;.   .  :  ','  ....   ,  ....,,~,~q~:.~:.   . . . .  ,.   ,   .  ..,   9 ..".:~-.-.:;,,;:
                                                     ....~:~,~,:,;:
                                                                       ",:...~;:.~:L~!i~.-,'....
                                      9   .    ..  ,..:...-~,?;~-.';:.'   ...;..
                                 'i':.  ,',   .   '    . .... ,~,.
                          .
                           ";'r,,:~u'r;        '
                            Before treatment             After radiotherapy
                           38.9            5.1           3s             17. 7
                               "~   44.0   J"               "~   ,57.2   ~"
                     FIG. 9.14.  Kidney function test by  X97HgCI2 using scintigraphy.  (From Kellershohn et al.)
   282   283   284   285   286   287   288   289   290   291   292